Key Takeaways Precision medicine uses a patient’s unique cancer genes to pick the best treatment. Molecular profiling is a test that finds the genes causing cancer. Targeted drugs attack specific cancer cells without harming healthy cells. Liquid biopsy is a simple blood test that finds cancer DNA. Genomic testing helps
Key Takeaways Malaysia is emerging as a premier destination for cancer treatment in Asia due to high-quality healthcare facilities and advanced medical expertise. The Malaysia healthcare system combines modern technology with affordable costs, attracting patients from across Southeast Asia and beyond. Private hospitals and government facilities provide comprehensive cancer care
Key Takeaways In Q2 2026, the FDA approved treatments across breast cancer, blood cancers, bladder cancer, prostate cancer, kidney cancer, and several rare cancer types. Many of these approvals target specific patient groups defined by genetic markers, mutations, or protein levels. Patients who hear about a new approval should ask
Key Takeaways New head & neck cancer trial shows strong early tumor response. Bispecific antibody injection may shrink or remove tumors. In 102 patients, 43 saw shrinkage and 15 had no detectable cancer. Median survival ~12.5 months (early results). Still experimental, needs phase 3 trials. Estimated read: ~3 min What
Key Takeaways A new study in the journal Radiology found that three commercial AI systems spotted breast cancer signs up to six years before diagnosis. About 20% of cancers showed mammographic changes that AI could read roughly six years before doctors confirmed the disease. Two years before diagnosis, the AI
Key Takeaways Onco Life Centre has achieved ACHSI accreditation, becoming Malaysia’s first non-hospital-based oncology provider to hold this global credential. ACHSI is the international arm of a not-for-profit Australian standards body with over 50 years of history in healthcare quality. The accreditation covers clinical outcomes, patient safety, and the complete
Quick Summary High-dose biotin (vitamin B7) supplements, often found in hair, skin, and nails products, can interfere with lab tests used to monitor prostate, thyroid, ovarian, and breast cancer. Biotin can cause falsely high or low results by disrupting chemical reactions in certain assays. Patients should tell their oncology team
Quick Summary A new liquid biopsy method (not yet ready for routine care) analyzes immune-related signals in blood to predict which breast cancer patients may benefit from immunotherapy. In a study of stage 2-3 HER2-negative breast cancer patients (546 blood samples from 160 patients), blood transcriptomic patterns linked T-cell activity
Quick Summary A Phase II clinical trial presented at AACR 2026 found that long-term immunotherapy with atezolizumab may be safe for alveolar soft part sarcoma (ASPS) patients beyond the traditional 2-year window. Among 17 patients treated for over 2 years (up to 5+ years), only 3 experienced moderate side effects,
Quick Summary Scientists have engineered probiotic bacteria (E. coli Nissle 1917) to locate tumors and produce the cancer drug romidepsin directly inside the tumor microenvironment. In mouse models, this approach slowed tumor growth and may offer a more precise targeted therapy with fewer side effects than traditional chemotherapy. How it
